(1E,4E)-1,5-Bis(2-Methoxyphenyl)penta-1,4-dien-3-one
(1E,4E)-1,5-Bis(2-Methoxyphenyl)penta-1,4-dien-3-one Basic information
- Product Name:
- (1E,4E)-1,5-Bis(2-Methoxyphenyl)penta-1,4-dien-3-one
- Synonyms:
-
- (1E,4E)-1,5-Bis(2-Methoxyphenyl)penta-1,4-dien-3-one
- 1,4-Pentadien-3-one, 1,5-bis(2-Methoxyphenyl)-, (1E,4E)-
- Curcumin analog C1
- 1,5-Bis-(2-methoxy-phenyl)-penta-1,4-dien-3-one
- TFEB activator 1
- (1E,4E)-1,5-Bis(2-Methoxyphenyl)penta-1
- Curcumin analog compound C1
- RPN77612
- CAS:
- 39777-61-2
- MF:
- C19H18O3
- MW:
- 294.34
- Mol File:
- 39777-61-2.mol
(1E,4E)-1,5-Bis(2-Methoxyphenyl)penta-1,4-dien-3-one Chemical Properties
- Melting point:
- 120-122 °C(Solv: ethanol (64-17-5); water (7732-18-5))
- Boiling point:
- 467.2±40.0 °C(Predicted)
- Density
- 1.128±0.06 g/cm3(Predicted)
- storage temp.
- 2-8°C
- solubility
- DMSO: 125 mg/mL (424.68 mM)
- form
- A solid
- color
- Light yellow to yellow
- InChI
- InChI=1S/C19H18O3/c1-21-18-9-5-3-7-15(18)11-13-17(20)14-12-16-8-4-6-10-19(16)22-2/h3-14H,1-2H3/b13-11+,14-12+
- InChIKey
- RCZMPCUUTSDNAJ-PHEQNACWSA-N
- SMILES
- C(/C1=CC=CC=C1OC)=C\C(=O)/C=C/C1=CC=CC=C1OC
(1E,4E)-1,5-Bis(2-Methoxyphenyl)penta-1,4-dien-3-one Usage And Synthesis
Uses
TFEB activator 1 is an orally effective, mTOR-independent activator of TFEB. TFEB activator 1 significantly promotes the nuclear translocation of Flag-TFEB with an EC50 of 2167 nM. TFEB activator 1 enhances autophagy without inhibiting the mTOR pathway and has the potential for neurodegenerative diseases treatment[1].
in vivo
The medium lethal dose (LD50) value of TFEB activator 1 (Compound C1) is 175 mg/kg in the acute toxicity assay (single-dose i.v. tail vein injection; in rats) [1].
?
Short-term oral administration of TFEB activator 1 (low dosage 10 mg/kg and high dosage 25 mg/kg; for 24 h) dose-dependently increases the expression of LC3B-II and TFEB in the liver, frontal cortex and striatum of the brain[1].
?
Chronic administration of TFEB activator 1 (10 mg/kg per day; orally administered by gavage) activates TFEB and enhances autophagy in rat brains[1].
| Animal Model: | Adult male Sprague-Dawley (SD) rats weighing 350 to 400 g[1] |
| Dosage: | 10 mg/kg and 25 mg/kg |
| Administration: | Short-term oral administration; for 24 hours |
| Result: | Activated TFEB and enhanced autophagy and lysosome biogenesis in rat brain. |
| Animal Model: | Adult male Sprague-Dawley (SD) rats weighing 350 to 400 g[1] |
| Dosage: | 10 mg/kg |
| Administration: | Chronic oral administration; daily; for 21 days |
| Result: | Activated TFEB and enhanced autophagy in rat brains. |
References
[1] Song JX, et al. A novel curcumin analog binds to and activates TFEB in vitro and in vivo independent of MTOR inhibition. Autophagy. 2016 Aug 2;12(8):1372-89. DOI:10.1080/15548627.2016.1179404
(1E,4E)-1,5-Bis(2-Methoxyphenyl)penta-1,4-dien-3-oneSupplier
- Tel
- 13549236410
- sales@invivochem.cn
- Tel
- 021-31433387 15618786686
- sales@rechemscience.com
- Tel
- +86057186818502 13588463833
- info@sagechem.com
- Tel
- 400-400-164-7117 18317119277
- product02@bidepharm.com
- Tel
- 18122150900
- sculk28@163.com